The 2006 NRC Report was commissioned by the EPA. It is required to reconsider maximum fluoridation levels every ten years.
Buy the book or read it page-by-page:
The 2006 NRC Report was not commissioned to address the question of water fluoridation, and the authors were told not to address it. Its purpose was to examine the 4 ppm maximum contaminant level (MCL) and the 2 ppm maximum contaminant level goal (MCLG) to determine if they provided an adequate measure of protection.
The 4 ppm MCL is the maximum amount of fluoride which may legally be allowed in drinking water, and if fluoride is present at higher than 4 ppm, the water district is to remove the excess. The 4 ppm MCL is not an authorization to add fluoridation up to the 4 ppm limit. The EPA is forbidden in the Safe Drinking Water Act from reqiring the addition to drinking water of any form of medication.
NRC – Recommendations
I went through the NRC, Fluoride in Drinking Water book and extracted only the recommendations. They can view them in a short 9 page summary.
http://health.groups.yahoo.com/group/FluoridePoisoning/message/9339
Each section has recommendations for more research, proving that the uncertainties of fluoride are not an illusion. What is more disturbing is that less than 5 of all the studies used silicofluorides, the chemical used in most water fluoridation.
NRC recommendations
FLUORIDE IN DRINKING WATER
A SCIENTIFIC REVIEW OF EPA’S STANDARDS
Committee on Fluoride in Drinking Water
Board on Environmental Studies and Toxicology
Division on Earth and Life Studies
NATIONAL RESEARCH COUNCIL OF THE NATIONAL ACADEMIES
THE NATIONAL ACADEMIES PRESS
Washington, D.C.
Summary
RESEARCH NEEDS
As noted above, gaps in the information on fluoride prevented the committee from
making some judgments about the safety or the risks of fluoride at concentrations of 2 to 4 mg/L.
The following research will be useful for filling those gaps and guiding revisions to the MCLG
and SMCL for fluoride.
• Exposure assessment
— Improved assessment of exposure to fluoride from all sources is needed for a
variety of populations (e.g., different socioeconomic conditions). To the extent possible,
exposures should be characterized for individuals rather than communities, and epidemiologic
studies should group individuals by exposure level rather than by source of exposure, location of
residence, or fluoride concentration in drinking water. Intakes or exposures should be
characterized with and without normalization for body weight. Fluoride should be included in
nationwide biomonitoring surveys and nutritional studies; in particular, analysis of fluoride in
blood and urine samples taken in these surveys would be valuable.
• Pharmacokinetic studies
— The concentrations of fluoride in human bone as a function of exposure
concentration, exposure duration, age, sex, and health status should be studied. Such studies
would be greatly aided by noninvasive means of measuring bone fluoride. Information is
particularly needed on fluoride plasma and bone concentrations in people with small-to-moderate
changes in renal function as well as in those with serious renal deficiency.
— Improved and readily available pharmacokinetic models should be developed.
Additional cross-species pharmacokinetic comparisons would help to validate such models.
• Studies of enamel fluorosis
— Additional studies, including longitudinal studies, should be done in U.S.
communities with water fluoride concentrations greater than 1 mg/L. These studies should focus
on moderate and severe enamel fluorosis in relation to caries and in relation to psychological,
behavioral, and social effects among affected children, their parents, and affected children after
they become adults.
— Methods should be developed and validated to objectively assess enamel fluorosis.
Consideration should be given to distinguishing between staining or mottling of the anterior teeth
and of the posterior teeth so that aesthetic consequences can be more easily assessed.
— More research is needed on the relation between fluoride exposure and dentin
fluorosis and delayed tooth eruption patterns.
10 FLUORIDE IN DRINKING WATER: A SCIENTIFIC REVIEW OF EPA’S STANDARDS
• Bone studies
— A systematic study of clinical stage II and stage III skeletal fluorosis should be
conducted to clarify the relationship between fluoride ingestion, fluoride concentration in bone,
and clinical symptoms.
— More studies of communities with drinking water containing fluoride at 2 mg/L or
more are needed to assess potential bone fracture risk at these higher concentrations.
Quantitative measures of fracture, such as radiologic assessment of vertebral body collapse,
should be used instead of self-reported fractures or hospital records. Moreover, if possible, bone
fluoride concentrations should be measured in long-term residents.
• Other health effects
— Carefully conducted studies of exposure to fluoride and emerging health
parameters of interest (e.g., endocrine effects and brain function) should be performed in
populations in the United States exposed to various concentrations of fluoride. It is important
that exposures be appropriately documented.
2
Measures of Exposure to Fluoride in the United States
RECOMMENDATIONS
• Fluoride should be included in nationwide biomonitoring surveys and nutritional studies
(e.g., CDC’s National Health and Nutrition Examination Survey and affiliated studies). In
particular, analysis of fluoride in blood and urine samples taken in these surveys would be
valuable.
• National data on fluoridation (e.g., CDC 1993) should be updated on a regular basis.
• Probabilistic analysis should be performed for the uncertainty in estimates of individual
and group exposures and for population distributions of exposure (e.g., variability with respect to
long-term water consumption). This would permit estimation of the number of people exposed
at various concentrations, identification of population subgroups at unusual risk for high
exposures, identification or confirmation of those fluoride sources with the greatest impact on
individual or population exposures, and identification or characterization of fluoride sources that
are significant contributors to total exposure for certain population subgroups.
• To assist in estimating individual fluoride exposure from ingestion, manufacturers and
producers should provide information on the fluoride content of commercial foods and
beverages.
• To permit better characterization of current exposures from airborne fluorides, ambient
concentrations of airborne hydrogen fluoride and particulates should be reported on national and
regional scales, especially for areas of known air pollution or known sources of airborne
72 FLUORIDE IN DRINKING WATER: A SCIENTIFIC REVIEW OF EPA’S STANDARDS
fluorides. Additional information on fluoride concentrations in soils in residential and
recreational areas near industrial fluoride sources also should be obtained.
• Additional studies on the relationship between individual fluoride exposures and
measurements of fluoride in tissues (especially bone and nails) and bodily fluids (especially
serum and urine) should be conducted. Such studies should determine both absolute intakes
(mg/day) and body-weight normalized intakes (mg/kg/day).
• Assumptions about the influence of environmental factors, particularly temperature, on
water consumption should be reevaluated in light of current lifestyle practices (e.g., greater
availability of air conditioning, participation in indoor sports).
• Better characterization of exposure to fluoride is needed in epidemiology studies
investigating potential effects. Important exposure aspects of such studies would include the
following:
– collecting data on general dietary status and dietary factors that could influence
exposure or effects, such as calcium, iodine, and aluminum intakes
– characterizing and grouping individuals by estimated (total) exposure, rather
than by source of exposure, location of residence, fluoride concentration in drinking
water, or other surrogates
– reporting intakes or exposures with and without normalization for body weight
(e.g., mg/day and mg/kg/day)
– addressing uncertainties associated with exposure, including uncertainties in
measurements of fluoride concentrations in bodily fluids and tissues
– reporting data in terms of individual correlations between intake and effect,
differences in subgroups, and differences in percentages of individuals showing an effect
and not just differences in group or population means.
• Further analysis should be done of the concentrations of fluoride and various fluoride
species or complexes (especially fluorosilicates and aluminofluorides) present in tap water, using
a range of water samples (e.g., of different hardness and mineral content). Research also should
include characterizing any changes in speciation that occur when tap water is used for various
purposes—for example, to make acidic beverages.
• The possibility of biological effects of SiF6
2-, as opposed to free fluoride ion, should be
examined.
• The biological effects of aluminofluoride complexes should be researched further,
including the conditions (exposure conditions and physiological conditions) under which the
complexes can be expected to occur and to have biological effects.
3
Pharmacokinetics of Fluoride
RESEARCH RECOMMENDATIONS
• Additional research is needed on fluoride concentrations in human bone as a function of
magnitude and duration of exposure, age, gender, and health status. Such studies would be
greatly aided by noninvasive means of measuring bone fluoride. As discussed in other chapters
of this report, some soft tissue effects may be associated with fluoride exposure. Most
measurements of fluoride in soft tissues are based on short-term exposures and some atypically
high values have been reported. Thus, more studies are needed on fluoride concentrations in soft
tissues (e.g., brain, thyroid, kidney) following chronic exposure.
• Research is needed on fluoride plasma and bone concentrations in people with small to
moderate changes in renal function as well as patients with serious renal deficiency. Other
potentially sensitive populations should be evaluated, including the elderly, postmenopausal
women, and people with altered acid-base balance.
• Improved and readily available pharmacokinetic models should be developed.
• Additional studies comparing pharmacokinetics across species are needed.
• More work is needed on the potential for release of fluoride by the metabolism of
organofluorines.
4
Effects of Fluoride on Teeth
RECOMMENDATIONS
• Additional studies, including longitudinal studies, of the prevalence and severity of
enamel fluorosis should be done in U.S. communities with fluoride concentrations higher than 1
mg/L. These studies should focus on moderate and severe enamel fluorosis in relation to caries
and in relation to psychological, behavioral, and social effects among affected children, their
parents, and affected children after they become adults.
• Methods should be developed and validated to objectively assess enamel fluorosis.
Consideration should be given to distinguishing between staining or mottling of the anterior teeth
and of the posterior teeth so that aesthetic consequences can be more easily assessed.
• More research is needed on the relation between fluoride exposure and dentin fluorosis
and delayed tooth eruption patterns.
5
Musculoskeletal Effects
RECOMMENDATIONS
• A more complete analysis of communities consuming water with fluoride at 2 and 4
mg/L is necessary to assess the potential for fracture risk at those concentrations. These studies
should use a quantitative measure of fracture such as radiological assessment of vertebral body
collapse rather than self-reported fractures or hospital records. Moreover, if possible, bone
fluoride concentrations should be measured in long-term residents.
MUSCULOSKELETAL EFFECTS 147
• The effects of fluoride exposure in bone cells in vivo depend on the local
concentrations surrounding the cells. More data are needed on concentration gradients during
active remodeling. A series of experiments aimed at quantifying the graded exposure of bone
and marrow cells to fluoride released by osteoclastic activity would go a long way in estimating
the skeletal effects of this agent.
• A systematic study of stage II and stage III skeletal fluorosis should be conducted to
clarify the relationship of fluoride ingestion, fluoride concentration in bone, and clinical
symptoms. Such a study might be particularly valuable in populations in which predicted bone
concentrations are high enough to suggest a risk of stage II skeletal fluorosis (e.g., areas with
water concentrations of fluoride above 2 mg/L).
• More research is needed on bone concentrations of fluoride in people with altered renal
function, as well as other potentially sensitive populations (e.g., the elderly, post-menopausal
women, people with altered acid-balance), to better understand the risks of musculoskeletal
effects in these populations.
6
Reproductive and Developmental Effects of Fluoride
RECOMMENDATIONS
• Studies in occupational settings are often useful in identifying target organs that might
be susceptible to disruption and in need of further evaluation at the lower concentrations of
exposure experienced by the general population. Therefore, carefully controlled studies of
occupational exposure to fluoride and reproductive parameters are needed to further evaluate the
possible association between fluoride and alterations in reproductive hormones reported by
Ortiz-Perez et al. (2003).
• Freni (1994) found an association between high fluoride concentrations (3 mg/L or
more) in drinking water and decreased total fertility rate. The overall study approach used by
Freni has merit and could yield valuable new information if more attention is given to controlling
for reproductive variables at the individual and group levels. Because that study had design
limitations, additional research is needed to substantiate whether an association exists.
• A reanalysis of data on Down’s syndrome and fluoride by Takahashi (1998) suggested a
possible association in children born to young mothers. A case-control study of the incidence of
Down’s syndrome in young women and fluoride exposure would be useful for addressing that
issue. However, it may be particularly difficult to study the incidence of Down’s syndrome
today given increased fetal genetic testing and concerns with confidentiality
7
Neurotoxicity and Neurobehavioral Effects
RECOMMENDATIONS
On the basis of information largely derived from histological, chemical, and molecular
studies, it is apparent that fluorides have the ability to interfere with the functions of the brain
and the body by direct and indirect means. To determine the possible adverse effects of fluoride,
additional data from both the experimental and the clinical sciences are needed.
• The possibility has been raised by the studies conducted in China that fluoride can
lower intellectual abilities. Thus, studies of populations exposed to different concentrations of
fluoride in drinking water should include measurements of reasoning ability, problem solving,
IQ, and short- and long-term memory. Care should be taken to ensure that proper testing
methods are used, that all sources of exposure to fluoride are assessed, and that comparison
populations have similar cultures and socioeconomic status.
• Studies of populations exposed to different concentrations of fluoride should be
undertaken to evaluate neurochemical changes that may be associated with dementia.
Consideration should be given to assessing effects from chronic exposure, effects that might be
delayed or occur late-in-life, and individual susceptibility (see Chapter 2 and 3 for discussion of
subpopulations that might be more susceptible to the effects of fluoride from exposure and
physiologic standpoints, respectively).
• Additional animal studies designed to evaluate reasoning are needed. These studies
must be carefully designed to measure cognitive skills beyond rote learning or the acquisition of
simple associations, and test environmentally relevant doses of fluoride.
• At the present time, questions about the effects of the many histological, biochemical,
and molecular changes caused by fluorides cannot be related to specific alterations in behavior or
to known diseases. Additional studies of the relationship of the changes in the brain as they
affect the hormonal and neuropeptide status of the body are needed. Such relationships should
be studied in greater detail and under different environmental conditions.
• Most of the studies dealing with neural and behavioral responses have tested NaF. It is
important to determine whether other forms of fluoride (e.g., silicofluorides) produce the same
effects in animal models.
8
Effects on the Endocrine System
RECOMMENDATIONS
• Further effort is necessary to characterize the direct and indirect mechanisms of
fluoride’s action on the endocrine system and the factors that determine the response, if any, in a
given individual. Such studies would address the following:
— the in vivo effects of fluoride on second messenger function
— the in vivo effects of fluoride on various enzymes
— the integration of the endocrine system (both internally and with other systems
such as the neurological system)
— identification of those factors, endogenous (e.g., age, sex, genetic factors, or
preexisting disease) or exogenous (e.g., dietary calcium or iodine concentrations, malnutrition),
associated with increased likelihood of effects of fluoride exposures in individuals
— consideration of the impact of multiple contaminants (e.g., fluoride and
perchlorate) that affect the same endocrine system or mechanism
— examination of effects at several time points in the same individuals to identify
any transient, reversible, or adaptive responses to fluoride exposure.
• Better characterization of exposure to fluoride is needed in epidemiology studies
investigating potential endocrine effects of fluoride. Important exposure aspects of such studies
would include the following:
— collecting data on general dietary status and dietary factors that could influence the
response, such as calcium, iodine, selenium, and aluminum intakes
224 FLUORIDE IN DRINKING WATER: A SCIENTIFIC REVIEW OF EPA’S STANDARDS
— characterizing and grouping individuals by estimated (total) exposure, rather than
by source of exposure, location of residence, fluoride concentration in drinking water, or other
surrogates
— reporting intakes or exposures with and without normalization for body weight
(e.g., mg/day and mg/kg/day), to reduce some of the uncertainty associated with comparisons of
separate studies
— addressing uncertainties associated with exposure and response, including
uncertainties in measurements of fluoride concentrations in bodily fluids and tissues and
uncertainties in responses (e.g., hormone concentrations)
— reporting data in terms of individual correlations between intake and effect,
differences in subgroups, and differences in percentages of individuals showing an effect and not
just differences in group or population means.
— examining a range of exposures, with normal or control groups having very low
fluoride exposures (below those associated with 1 mg/L in drinking water for humans).
• The effects of fluoride on various aspects of endocrine function should be examined
further, particularly with respect to a possible role in the development of several diseases or
mental states in the United States. Major areas for investigation include the following:
— thyroid disease (especially in light of decreasing iodine intake by the U.S.
population);
— nutritional (calcium-deficiency) rickets;
— calcium metabolism (including measurements of both calcitonin and PTH);
— pineal function (including, but not limited to, melatonin production); and development of glucose intolerance and diabetes.
9
Effects on the Gastrointestinal, Renal,
Hepatic, and Immune Systems
RECOMMENDATIONS
Gastric Effects
• Studies are needed to evaluate gastric responses to fluoride from natural sources at
concentrations up to 4 mg/L and from artificial sources. Data on both types of exposures would
help to distinguish between the effects of water fluoridation chemicals and natural fluoride.
Consideration should be given to identifying groups that might be more susceptible to the gastric
effects of fluoride.
• The influence of fluoride and other minerals, such as calcium and magnesium, present
in water sources containing natural concentrations of fluoride up to 4 mg/L on gastric responses
should be carefully measured.
Renal and Hepatic Effects
• Rigorous epidemiologic studies should be carried out in North America to determine
whether fluoride in drinking water at 4 mg/L is associated with an increased incidence of kidney
stones. There is a particular need to study patients with renal impairments.
• Additional studies should be carried out to determine the incidence, prevalence, and
severity of renal osteodystrophy in patients with renal impairments in areas where there is
fluoride at up to 4 mg/L in the drinking water.
• The effect of low doses of fluoride on kidney and liver enzyme functions in humans
needs to be carefully documented in communities exposed to different concentrations of fluoride
in drinking water.
Immune Response
• Epidemiologic studies should be carried out to determine whether there is a higher
prevalence of hypersensitivity reactions in areas where there is elevated fluoride in the drinking
water. If evidence is found, hypersensitive subjects could then be selected to test, by means of
Effects on the Gastrointestinal, Renal, Hepatic, and Immune Systems 259
double-blinded randomized clinical trials, which fluoride chemicals can cause hypersensitivity.
In addition, studies could be conducted to determine what percentage of immunocompromised
subjects have adverse reactions when exposed to fluoride in the range of 1-4 mg/L in drinking
water.
• More research is needed on the immunotoxic effects of fluoride in animals and humans
to determine if fluoride accumulation can influence immune function.
• It is paramount that careful biochemical studies be conducted to determine what
fluoride concentrations occur in the bone and surrounding interstitial fluids from exposure to
fluoride in drinking water at up to 4 mg/L, because bone marrow is the source of the progenitors
that produce the immune system cells.
10
Genotoxicity and Carcinogenicity
RECOMMENDATIONS
Carcinogenicity
• The results of the Douglass et al. multicenter osteosarcoma study (expected in the
summer of 2006) could add important data to the current body of literature on fluoride risks for
osteosarcoma because the study includes bone fluoride concentrations for cases and controls.
When this study is published, it should be considered in context with the existing body of evidence
to help determine what follow-up studies are needed.
• Further research on a possible effect of fluoride on bladder cancer risk should be conducted.
Since bladder cancer is relatively common (compared with osteosarcoma), both cohort
and case-control designs would be feasible to address this question. For example, valuable data
might be yielded by analyses of cancer outcomes among the cohorts followed for other health
outcomes, such as fractures (see Chapter 5).
Genotoxicity
• The positive in vivo genotoxicity studies described in the chapter were conducted in India
and China, where fluoride concentrations in drinking water are often higher than those in the
United States. Further, each had a dearth of information on the selection of subjects and was
based on small numbers of participants. Therefore, in vivo human genotoxicity studies in U.S.
populations or other populations with nutritional and sociodemographic variables similar to those
in the United States should be conducted. Documentation of subject enrollment with different
fluoride concentrations would be useful to addressing the potential genotoxic hazards of fluoridated
water in this country.
11
Drinking Water Standards for Fluoride
FINDINGS AND RECOMMENDATIONS
Maximum-Contaminant-Level Goal
In light of the collective evidence on various health end points and total exposure to
fluoride, the committee concludes that EPA’s MCLG of 4 mg/L should be lowered. Lowering
the MCLG will prevent children from developing severe enamel fluorosis and will reduce the
lifetime accumulation of fluoride into bone that the majority of the committee concluded is likely
to put individuals at increased risk of bone fracture and possibly skeletal fluorosis, which are
particular concerns for subpopulations that are prone to accumulating fluoride in their bone.
Recommendation: To develop an MCLG that is protective of severe enamel fluorosis,
clinical stage II skeletal fluorosis, and bone fractures, EPA should update the risk assessment of
fluoride to include new data on health risks and better estimates of total exposure (relative
source contribution) in individuals and to use current approaches to quantifying risk,
considering susceptible subpopulations, and characterizing uncertainties and variability.
Secondary Maximum Contaminant Level
The prevalence of severe enamel fluorosis is very low (near zero) at fluoride
concentrations below 2 mg/L. However, from a cosmetic standpoint, the SMCL does not
completely prevent the occurrence of moderate enamel fluorosis. EPA has indicated that the
SMCL was intended to reduce the severity and occurrence of the condition to 15% or less of the
exposed population. The available data indicates that fewer than 15% of children would
experience moderate enamel fluorosis of aesthetic concern (discoloration of the front teeth).
However, the degree to which moderate enamel fluorosis might go beyond a cosmetic effect to
create an adverse psychological effect or an adverse effect on social functioning is not known.
Recommendations: Additional studies, including longitudinal studies, of the prevalence
and severity of enamel fluorosis should be done in U.S. communities with fluoride concentrations
greater than 1 mg/L. These studies should focus on moderate and severe enamel fluorosis in
relation to caries and in relation to psychological, behavioral, and social effects among affected
children, among their parents, and among affected children after they become adults.
To better define the aesthetics of enamel fluorosis, methods should be developed and
validated to objectively assess enamel fluorosis. Staining and mottling of the anterior teeth
should be distinguished from staining of the posterior teeth so that aesthetic consequences can
be more easily assessed.